MEDP logo

MEDP

Medpace Holdings Inc.

$591.82
+$5.66(+0.97%)
56
Overall
50
Value
63
Tech
--
Quality
Market Cap
$14.01B
Volume
253.16K
52W Range
$250.05 - $625.00
Target Price
$557.27

Company Overview

Mkt Cap$14.01BPrice$591.82
Volume253.16KChange+0.97%
P/E Ratio34.6Open$587.00
Revenue$2.1BPrev Close$586.16
Net Income$404.4M52W Range$250.05 - $625.00
Div YieldN/ATarget$557.27
Overall56Value50
Quality--Technical63

No chart data available

About Medpace Holdings Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Sector: Healthcare
Industry: Diagnostics & Research

Latest News

Tenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF

Tenax Therapeutics (($TENX)), Medpace Holdings Inc (($MEDP)) announced an update on their ongoing clinical study. Tenax Therapeutics, in collaborat...

TipRanks Clinical-Trials-Auto-Generated Newsdeska month ago
ABCD
1SymbolPriceChangeVol
2MEDP$591.82+1.0%253.16K
3
4
5
6

Get Medpace Holdings Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.